New Category III Codes Facilitate Integration of CaRi-Heart® into Clinical Practice for Enhanced Cardiac Risk Assessment...
Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatments...
New Infusion Devices Enhance Accuracy and Expand ICU Medical's IV Performance Platform...
Advanced Machine Learning Tool Integrates with Shoulder Planning App to Personalize Surgical Predictions...
Research Presented at Radiosurgery Society Meeting Showcases Precision and Clinical Advantages ...
Advanced Features Enhance Diagnostic Precision and Workflow Efficiency ...
Advanced Diagnostic Technology Aims to Enhance Detection of Connective Tissue Diseases ...
Digital Therapeutic Enhances Mobility and Quality of Life for PD Patients...
Funding to Support Innovation and Global Expansion in Robotic Surgery...
• One-third of all deaths in Singapore are caused by cardiovascular disease (CVD), with stroke, and myocardial infarction (MI) being the leading causes of death, driving the need for percutaneous coronary intervention (PCI) • Building upon the results of the BIOADAPTOR RCT (randomized clinical trial), the 12- month data from the INFINITY-SWEDEHEART trial further validates the DynamX® Coronary Bioadaptor System’s unique mechanism of action in complex PCI population subsets • The 12 months’ ...
